Wells Fargo & Company »

Taysha Gene Therapies shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 7.4k 1.77
2023-09-30 $21k 6.5k 3.16
2023-06-30 $13k 19k 0.66
2022-12-31 $2.9k 1.3k 2.26
2022-09-30 $0 950 0.00
2022-06-30 $1.0k 163 6.14
2022-03-31 $9.0k 1.4k 6.23
2021-12-31 $110k 9.5k 11.63
2021-03-31 $1.2M 57k 20.31
2020-12-31 $330k 12k 26.48